On January 1, 2018, NexImmune, Inc. closed the transaction. The company has received $23,000,000 in its series A round of funding co-led by new investor ArrowMark Colorado Holdings, LLC and existing investor Barer & Son Capital. The transaction also involved participation from 69 investors including existing investor Piedmont Capital Partners LLC and individual investor Bill Hawkins. Pursuant to the transaction Tony Yaoof ArrowMark Colorado Holdings, LLC will join the board of directors.